Measles vaccine and its use in developing countries.
D000917:Antibody Formation; D002648:Child; D002677:Chile; D003365:Costs and Cost Analysis; D003906:Developing Countries; D004338:Drug Combinations; D005334:Fever / Q000209:etiology; D006801:Humans; D006967:Hypersensitivity; D007492:Iran; D008457:Measles / Q000276:immunology / Q000401:mortality; D008458:Measles Vaccine / Q000009:adverse effects; D010919:Placebos; D012141:Respiratory Tract Infections / Q000209:etiology; D012640:Seizures / Q000209:etiology; D013997:Time Factors; D005719:gamma-Globulins
D004338:Drug Combinations; D008458:Measles Vaccine; D010919:Placebos; D005719:gamma-Globulins